Accendra Health Inc (ACH): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$13.00M
Year ended 2024-12-31
2021-12-31: $12.10M2022-12-31: $12.00M2023-12-31: $13.00M2024-12-31: $13.00M$13.00M
2021-12-31 R&D Expense (USD) 2024-12-31
Period endedR&D ExpenseChange YoYSource filing
2024-12-31$13.00M0.0%2025-02-28, From 2024-01-01
2023-12-31$13.00M+8.3%2025-02-28, From 2023-01-01
2022-12-31$12.00Mn/c2025-02-28, From 2022-01-01
2021-12-31$12.10Mn/a2024-02-20, From 2021-01-01